SynthesisThe Cochrane database of systematic reviews2025

Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation.

Mario Occhipinti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.